Cherry Brian N
SEC Form 4 insider trading activity
Cherry Brian N has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Cherry Brian N is listed as Director at Atara Biotherapeutics, Inc. Inside the rolling window, Cherry Brian N reported 1 open-market purchase totaling $1000K in ATRA and no open-market sales.
Companies traded
Other insiders at ATRA
Insider Buying
$1000K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cherry Brian N made?
Cherry Brian N has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Cherry Brian N trade?
Cherry Brian N has filed SEC Form 4 disclosures for 1 company, including ATRA.
When was Cherry Brian N's most recent SEC Form 4 filing?
Cherry Brian N's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Cherry Brian N's total buy and sell value in the current window?
Inside the rolling retention window, Cherry Brian N bought $1000K and sold $0 based on SEC Form 4 filings.
What was Cherry Brian N's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 104,166 ATRA shares on 2026-09-04, worth $1000K, per SEC Form 4 filings.